Top Articles - Finance

Let's be clear about this. Not all debt management companies are in the busin

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ess of ripping their customers off but a vast amount of them are.

Surely the

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

point of a debt management company is to do exactly that - manage your debt s

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ituation. This should mean that they charge minimum fees or no fees at all, a

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ter all, most of the people they are helping are people who have got themselv

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

s into an unfortunate situation that requires a debt management solution. Thi

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

s would also mean that the people in this situation are the type who have no

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

pare disposable income and money (or rather saving money) becomes the No.1 ob

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

ective.

Why is then that certain companies are charging clients up to 5% of

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

the loan or remortgage, just for consolidating their debts? It is absolutely

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

taggering and something should be done about it, whether by Government legisl

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

tion or by the financial services industry regulating themselves properly for

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

a change. It is all well and good, saying that it doesn't make a lot of diff

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

rence to the client as the charge is added onto their final loan amount but i

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

my eyes this is still tantamount to daylight robbery.

Surely this situation

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

is one where the clients are desperate for good solid financial advice and n

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

t be at the mercy of mortgage brokers and debt management companies who care

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

nly for their commission and not for the clients well being.

The message is

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

to choose your debt management company very carefully and check out the facts

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

No charges
or
Maximum charge of .5% added on to the loan

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Top Articles - Don't Get Ripped Off By Debt Management Companies

Related Articles: